First Wave BioPharma Probability of Future Stock Price Finishing Over 0.61
| FWBIDelisted Stock | USD 0.61 0.03 4.69% |
First |
First Wave Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of First Wave for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for First Wave BioPharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| First Wave BioPharma is now traded under the symbol ENTO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| First Wave BioPharma is not yet fully synchronised with the market data | |
| First Wave BioPharma has some characteristics of a very speculative penny stock | |
| First Wave BioPharma has a very high chance of going through financial distress in the upcoming years | |
| First Wave BioPharma currently holds 826.84 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. First Wave BioPharma has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about First Wave's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (15.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| First Wave BioPharma currently holds about 1.16 M in cash with (12.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
First Wave Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of First Stock often depends not only on the future outlook of the current and potential First Wave's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. First Wave's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 336.3 K | |
| Cash And Short Term Investments | 3.7 M |
First Wave Technical Analysis
First Wave's future price can be derived by breaking down and analyzing its technical indicators over time. First Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of First Wave BioPharma. In general, you should focus on analyzing First Stock price patterns and their correlations with different microeconomic environments and drivers.
First Wave Predictive Forecast Models
First Wave's time-series forecasting models is one of many First Wave's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary First Wave's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about First Wave BioPharma
Checking the ongoing alerts about First Wave for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for First Wave BioPharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| First Wave BioPharma is now traded under the symbol ENTO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| First Wave BioPharma is not yet fully synchronised with the market data | |
| First Wave BioPharma has some characteristics of a very speculative penny stock | |
| First Wave BioPharma has a very high chance of going through financial distress in the upcoming years | |
| First Wave BioPharma currently holds 826.84 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. First Wave BioPharma has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about First Wave's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (15.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| First Wave BioPharma currently holds about 1.16 M in cash with (12.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in First Stock
If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |